SV Health Investors, LLC - Q3 2021 holdings

$204 Million is the total value of SV Health Investors, LLC's 8 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 14.3% .

 Value Shares↓ Weighting
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$59,742,000
+2.7%
1,436,456
-25.0%
29.23%
+15.4%
AHCO SellADAPTHEALTH CORP$45,209,000
-43.4%
1,941,118
-33.3%
22.12%
-36.4%
MSON  MISONIX, INC.$42,859,000
+14.1%
1,694,0170.0%20.97%
+28.1%
STRO  SUTRO BIOPHARMA INC$34,466,000
+1.6%
1,824,5420.0%16.86%
+14.1%
DCPH  DECIPHERA PHARMACEUTICALS INC$15,289,000
-7.2%
449,9510.0%7.48%
+4.3%
RGEN NewRepligen Corporation$4,203,00014,541
+100.0%
2.06%
XFOR  X4 PHARMACEUTICALS INC$1,648,000
-18.6%
311,4900.0%0.81%
-8.6%
ASXC  ASENSUS SURGICAL, INC.$944,000
-41.7%
510,1420.0%0.46%
-34.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • SVLSF VI, LLC #1
  • SV Life Sciences Fund VI (GP), L.P. #2
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSENTERIX, INC.27Q4 202024.0%
OCULAR THERAPEUTIX, INC.24Q2 202035.9%
KALVISTA PHARMACEUTICALS INC17Q4 202031.0%
DECIPHERA PHARMACEUTICALS INC17Q3 202131.0%
CATABASIS PHARMACEUTICALS, INC.15Q4 201818.2%
X4 PHARMACEUTICALS INC15Q3 20223.2%
BICYCLE THERAPEUTICS PLC14Q3 202265.4%
SUTRO BIOPHARMA INC14Q4 202119.1%
ENTELLUS MED INC12Q4 201764.4%
AVROBIO INC12Q1 202141.6%

View SV Health Investors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-07
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-12
13F-HR2020-08-14

View SV Health Investors, LLC's complete filings history.

Compare quarters

Export SV Health Investors, LLC's holdings